ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation

Jieya Shao, William J. Welch, Marc I. Diamond

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Polyglutamine expansion in huntingtin (Htt) and the androgen receptor (AR) causes untreatable neurodegenerative diseases. Y-27632, a therapeutic lead, reduces Htt and AR aggregation in cultured cells, and Htt-induced neurodegeneration in Drosophila. Y-27632 inhibits both Rho-associated kinases ROCK and PRK-2, making its precise intracellular target uncertain. Over-expression of either kinase increases Htt and AR aggregation. Three ROCK inhibitors (Y-27632, HA-1077, and H-1152P), and a specific ROCK inhibitory peptide reduce polyglutamine protein aggregation, as does knockdown of ROCK or PRK-2 by RNAi. RNAi also indicates that each kinase is required for the inhibitory effects of Y-27632 to manifest fully. These two actin regulatory kinases are thus involved in polyglutamine aggregation, and their simultaneous inhibition may be an important therapeutic goal.

Original languageEnglish (US)
Pages (from-to)1637-1642
Number of pages6
JournalFEBS Letters
Volume582
Issue number12
DOIs
StatePublished - May 28 2008

Fingerprint

Androgen Receptors
Agglomeration
Receptor Aggregation
Phosphotransferases
RNA Interference
Neurodegenerative diseases
rho-Associated Kinases
Neurodegenerative Diseases
Drosophila
Actins
Cultured Cells
Cells
Peptides
polyglutamine
Y 27632
Therapeutics
Proteins

Keywords

  • Androgen receptor
  • Huntingtin
  • Neurodegeneration
  • Polyglutamine
  • PRK-2
  • ROCK

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation. / Shao, Jieya; Welch, William J.; Diamond, Marc I.

In: FEBS Letters, Vol. 582, No. 12, 28.05.2008, p. 1637-1642.

Research output: Contribution to journalArticle

Shao, Jieya ; Welch, William J. ; Diamond, Marc I. / ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation. In: FEBS Letters. 2008 ; Vol. 582, No. 12. pp. 1637-1642.
@article{47ceeac89fc44cbab591c2dee6aace17,
title = "ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation",
abstract = "Polyglutamine expansion in huntingtin (Htt) and the androgen receptor (AR) causes untreatable neurodegenerative diseases. Y-27632, a therapeutic lead, reduces Htt and AR aggregation in cultured cells, and Htt-induced neurodegeneration in Drosophila. Y-27632 inhibits both Rho-associated kinases ROCK and PRK-2, making its precise intracellular target uncertain. Over-expression of either kinase increases Htt and AR aggregation. Three ROCK inhibitors (Y-27632, HA-1077, and H-1152P), and a specific ROCK inhibitory peptide reduce polyglutamine protein aggregation, as does knockdown of ROCK or PRK-2 by RNAi. RNAi also indicates that each kinase is required for the inhibitory effects of Y-27632 to manifest fully. These two actin regulatory kinases are thus involved in polyglutamine aggregation, and their simultaneous inhibition may be an important therapeutic goal.",
keywords = "Androgen receptor, Huntingtin, Neurodegeneration, Polyglutamine, PRK-2, ROCK",
author = "Jieya Shao and Welch, {William J.} and Diamond, {Marc I.}",
year = "2008",
month = "5",
day = "28",
doi = "10.1016/j.febslet.2008.04.009",
language = "English (US)",
volume = "582",
pages = "1637--1642",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation

AU - Shao, Jieya

AU - Welch, William J.

AU - Diamond, Marc I.

PY - 2008/5/28

Y1 - 2008/5/28

N2 - Polyglutamine expansion in huntingtin (Htt) and the androgen receptor (AR) causes untreatable neurodegenerative diseases. Y-27632, a therapeutic lead, reduces Htt and AR aggregation in cultured cells, and Htt-induced neurodegeneration in Drosophila. Y-27632 inhibits both Rho-associated kinases ROCK and PRK-2, making its precise intracellular target uncertain. Over-expression of either kinase increases Htt and AR aggregation. Three ROCK inhibitors (Y-27632, HA-1077, and H-1152P), and a specific ROCK inhibitory peptide reduce polyglutamine protein aggregation, as does knockdown of ROCK or PRK-2 by RNAi. RNAi also indicates that each kinase is required for the inhibitory effects of Y-27632 to manifest fully. These two actin regulatory kinases are thus involved in polyglutamine aggregation, and their simultaneous inhibition may be an important therapeutic goal.

AB - Polyglutamine expansion in huntingtin (Htt) and the androgen receptor (AR) causes untreatable neurodegenerative diseases. Y-27632, a therapeutic lead, reduces Htt and AR aggregation in cultured cells, and Htt-induced neurodegeneration in Drosophila. Y-27632 inhibits both Rho-associated kinases ROCK and PRK-2, making its precise intracellular target uncertain. Over-expression of either kinase increases Htt and AR aggregation. Three ROCK inhibitors (Y-27632, HA-1077, and H-1152P), and a specific ROCK inhibitory peptide reduce polyglutamine protein aggregation, as does knockdown of ROCK or PRK-2 by RNAi. RNAi also indicates that each kinase is required for the inhibitory effects of Y-27632 to manifest fully. These two actin regulatory kinases are thus involved in polyglutamine aggregation, and their simultaneous inhibition may be an important therapeutic goal.

KW - Androgen receptor

KW - Huntingtin

KW - Neurodegeneration

KW - Polyglutamine

KW - PRK-2

KW - ROCK

UR - http://www.scopus.com/inward/record.url?scp=43549084329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549084329&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2008.04.009

DO - 10.1016/j.febslet.2008.04.009

M3 - Article

VL - 582

SP - 1637

EP - 1642

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 12

ER -